[144] Nuvation Bio Inc. SEC Filing

Rhea-AI Filing Summary

NUVB shareholder files notice to sell common shares under Rule 144. A holder of Class A common stock plans to sell 15,000 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $76,552.50. These shares were acquired on 11/19/2025 by exercising options under a registered plan for cash and will be sold as freely tradable stock. The notice also reports a prior sale over the past three months of 15,000 Class A common shares on 11/17/2025 for gross proceeds of $71,475. The form includes a representation that the selling holder is not aware of any undisclosed material adverse information about NUVB’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	76552.50	342833433	11/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	11/19/2025	Exercise of options under a registered plan	Issuer			15000	11/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DONGFANG LIU 1500 Broadway Suite 1401 New York NY 10036	Class A Common	11/17/2025	15000	71475.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NUVB Form 144 filing disclose?

The Form 144 discloses a planned sale of 15,000 shares of NUVB Class A common stock on the NYSE, with an aggregate market value of $76,552.50, by a shareholder relying on Rule 144.

How were the NUVB shares being sold under Form 144 acquired?

The 15,000 NUVB Class A common shares were acquired on 11/19/2025 through the exercise of options under a registered plan, with the purchase price paid in cash.

Which broker is handling the NUVB Rule 144 sale and on which exchange?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are expected to be sold on the NYSE.

How many NUVB shares are outstanding according to the Form 144?

The Form 144 notes that there are 342,833,433 shares of NUVB Class A common stock outstanding at the time referenced in the notice.

Were there any recent NUVB share sales by the same holder?

Yes. Over the prior three months, the same person sold 15,000 NUVB Class A common shares on 11/17/2025 for $71,475.00 in gross proceeds.

Does the NUVB Form 144 include a representation about undisclosed information?

Yes. The person on whose account the securities are to be sold represents that they do not know any material adverse information about NUVB’s current or prospective operations that has not been publicly disclosed.